We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HUB:ASXHUB24 Limited Analysis

Data as of 2026-03-11 - not real-time

A$87.34

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

HUB24 Limited is currently trading below its short‑term moving averages, with the price sitting beneath the 20‑day and 50‑day SMA, and the MACD line remains in a bearish configuration. The RSI is in the low‑forties, indicating limited upward momentum, while volume has been on a downtrend, reinforcing the bearish technical backdrop. Valuation metrics are stretched: the price‑to‑earnings multiple is well above the industry average and the market price exceeds the discounted cash‑flow fair value estimate, suggesting the stock is overvalued at present.
On the fundamentals side, the company delivers exceptional profitability, boasting gross margins near 94% and operating margins close to 30%, alongside robust revenue growth of over 25% year‑over‑year. Return on equity is healthy, and the dividend payout ratio under 50% supports dividend sustainability. However, the high beta and elevated 30‑day volatility point to pronounced price swings, and the bearish technical signals temper short‑term optimism despite the strong underlying business.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below key moving averages
  • bearish MACD and weakening volume
  • valuation gap between market price and DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong revenue growth and high profitability margins
  • sustainable dividend with moderate payout ratio
  • persistent overvaluation but improving earnings outlook

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • high gross and operating margins indicating durable competitive advantage
  • solid ROE and cash generation supporting long‑term cash flow
  • potential for price correction aligning market price with intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth26.20%
Profit Margin23.39%
P/E Ratio68.2
ROE19.73%
ROA15.82%
Debt/Equity11.45
P/B Ratio13.1
Op. Cash FlowA$160.6M
Industry P/E17.2

Technical Analysis

TrendBearish
RSI42.2
SupportA$74.92
ResistanceA$104.21
MA 20A$90.56
MA 50A$93.51
MA 200A$99.15
MACDBearish
VolumeDecreasing
Fear & Greed Index76.5

Valuation

Fair ValueA$52.45
Target PriceA$109.52
Upside/Downside25.40%
GradeOvervalued
TypeGrowth
Dividend Yield0.82%

Risk Assessment

Beta1.18
Volatility73.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.